Page last updated: 2024-09-04

butylscopolammonium bromide and Prostatic Neoplasms

butylscopolammonium bromide has been researched along with Prostatic Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albers, P; Antoch, G; Arsov, C; Blondin, D; Quentin, M; Rabenalt, R; Rubbert, C; Schimmöller, L; Schmaltz, AK; Ullrich, T1
Ashley, SA; deSouza, NM; Fisher, C; Morgan, VA; Parker, C; Payne, GS; Riches, SF; Vanas, NJ1
Doyle, CA; Hruby, G; Loadsman, JA1
Busch, J; Franiel, T; Hamm, B; Rief, M; Scheurig, C; Taupitz, M; Wagner, M1

Trials

1 trial(s) available for butylscopolammonium bromide and Prostatic Neoplasms

ArticleYear
Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate.
    European radiology, 2018, Volume: 28, Issue:1

    Topics: Aged; Artifacts; Butylscopolammonium Bromide; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Parasympatholytics; Prostate; Prostatic Neoplasms; ROC Curve

2018

Other Studies

3 other study(ies) available for butylscopolammonium bromide and Prostatic Neoplasms

ArticleYear
Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer.
    Clinical radiology, 2008, Volume: 63, Issue:7

    Topics: Aged; Butylscopolammonium Bromide; Diffusion Magnetic Resonance Imaging; Humans; Injections, Intramuscular; Male; Middle Aged; Neoplasm Staging; Parasympatholytics; Prospective Studies; Prostatic Neoplasms; Sensitivity and Specificity

2008
An audit of analgesia requirements for high-dose-rate prostate brachytherapy.
    Anaesthesia and intensive care, 2008, Volume: 36, Issue:5

    Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesia; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Brachytherapy; Butylscopolammonium Bromide; Humans; Male; Medical Audit; Middle Aged; Morphine; Muscarinic Antagonists; Oxycodone; Parasympatholytics; Postoperative Care; Prostatic Neoplasms; Radiotherapy Dosage; Retrospective Studies

2008
Effect of butylscopolamine on image quality in MRI of the prostate.
    Clinical radiology, 2010, Volume: 65, Issue:6

    Topics: Aged; Artifacts; Butylscopolammonium Bromide; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Injections, Intramuscular; Magnetic Resonance Imaging; Male; Middle Aged; Muscarinic Antagonists; Prostate; Prostatic Neoplasms; Retrospective Studies

2010